Discussion: The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants

Affiliations

Comment

Mark W Clemens. Plast Reconstr Surg. 2019 May.

. 2019 May;143(5):1295-1297.

doi: 10.1097/PRS.0000000000005588.

No abstract available

Comment on

The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants.
Magnusson M, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK. Magnusson M, et al. Plast Reconstr Surg. 2019 May;143(5):1285-1292. doi: 10.1097/PRS.0000000000005500. Plast Reconstr Surg. 2019. PMID: 30789476

1. Slovic P. Perception of risk. Science 1987;236:280–285.
1. Magnusson M, Beath K, Cooter R, et al. The epidemiology of breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstr Surg. 2019;143:1285–1292.
1. Loch-Wilkinson A, Beath KJ, Knight RJW, et al. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: High-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:645–654.
1. U.S. Food and Drug Administration. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Available at: https://www.fda.gov/medicaldevices/productsandmedicalprocedures/implants.... Accessed March 1, 2019.
1. Barr S, Hill EW, Bayat A. Functional biocompatibility testing of silicone breast implants and a novel classification system based on surface roughness. J Mech Behav Biomed Mater. 2017;75:75–81.